Merry Health International (02327) plans to acquire all shares of Jiangsu Yide for 125 million yuan

According to Zhitong Finance App, Meirui Health International (02327) announced that on January 8, 2026, the company (as the buyer) plans to acquire all shares in Jiangsu Yide from Yuye Group and Ms. Tan Wensheng (as the seller) at a total cost of RMB 125 million. On the same day, Mr. Zhou Xuzhou (as the guarantor) signed a letter of guarantee to provide the company with a personal guarantee to ensure that the seller fulfils its obligations under the share transfer agreement. After the acquisition is completed, the company will hold all of Jiangsu Yide's shares. As a result, Jiangsu Yide will become a wholly-owned subsidiary of the company, and its financial results will be incorporated into the Group's comprehensive financial statements.

Jiangsu Yide is a limited liability company established in China, mainly engaged in equity investment and property leasing business in China. The Group is mainly engaged in residential and commercial real estate business. In view of the excellent location of Yide Property, the board of directors plans to hold Yide Property for investment purposes through Jiangsu Yide and obtain rent income from it. The board of directors believes that the acquisition of Yide Property at a relatively competitive price to obtain potential capital appreciation and a source of future rental income would be beneficial to the Group. As of the date of this announcement, most Yide properties have been leased to independent third parties. The total annual rental income from Yide Property's lease is approximately RMB 7.8 million, and the corresponding rental return is approximately 5.97%. Considering the location advantage of Yide Property, the Group believes that the acquisition (that is, obtaining Yide Property through the acquisition of all shares in Jiangsu Yide) is expected to optimize the Group's revenue base and asset structure. The Group also believes that the acquisition will bring better cash flow prospects, potential capital appreciation space, and higher future returns.